Antibes, France

Emmanuelle At Guillet

This inventor holds 2 USPTO granted patents. Top assignee: Galderma Research & Development. Active years: 2018-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emmanuelle At Guillet. Retrieved from https://idiyas.com/inventor/emmanuelle-at-guillet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2021

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Emmanuelle At Guillet: Innovator in Dermatological Compositions

Introduction

Emmanuelle At Guillet is a notable inventor based in Antibes, France. She has made significant contributions to the field of dermatology through her innovative formulations. With a total of 2 patents, her work focuses on developing effective treatments for skin conditions.

Latest Patents

Her latest patents include formulations for cream gels that comprise at least one retinoid and benzoyl peroxide. These stable cream gel dermatological and cosmetic compositions are particularly useful for the treatment of acne vulgaris. They contain a homogeneous dispersion of at least one dispersed retinoid, dispersed benzoyl peroxide, at least one lipophilic compound, and at least one gelling agent, all formulated into a physiologically acceptable medium.

Career Highlights

Emmanuelle At Guillet is associated with Galderma Research & Development, where she continues to advance her research in dermatological compositions. Her work has been instrumental in creating effective solutions for skin care.

Collaborations

Some of her notable coworkers include Claire Mallard and Fabienne Louis, who contribute to the collaborative efforts in research and development at Galderma.

Conclusion

Emmanuelle At Guillet's innovative work in dermatological compositions highlights her commitment to improving skin health through scientific advancements. Her contributions are paving the way for more effective treatments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…